Form 4: Lexaria Bioscience Corp. Director John Docherty Reports Acquisition of 150,000 Stock Options
SEC Form 4 Filing
John Docherty, President and Director of Lexaria Bioscience Corp., reports the acquisition of 150,000 stock options.
Summary
- On May 15, 2025, John Docherty, President and Director of Lexaria Bioscience Corp., acquired 150,000 stock options with an exercise price of $1.04, exercisable from May 15, 2025, and expiring on May 15, 2030.
- Following this transaction, Docherty directly owns 310,834 stock options.
- He also indirectly owns 54,075 common shares through a private holding company.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it is a standard disclosure of stock option acquisition by a company director.
Industry Context
This Form 4 filing is a routine disclosure related to insider transactions and is a standard practice for publicly traded companies. It provides transparency into the trading activities of company insiders.
Stakeholder Impact
- The acquisition of stock options by a director can be viewed positively by shareholders as it aligns the director's interests with the company's long-term success.
Key Dates
| Date | Description |
|---|---|
| 04/26/2021 | Date of exercisable stock options with an expiration date of 04/26/2026 |
| 06/08/2021 | Date of exercisable stock options with an expiration date of 06/08/2026 |
| 09/01/2021 | Date of exercisable stock options with an expiration date of 09/01/2026 |
| 08/29/2022 | Date of exercisable stock options with an expiration date of 08/29/2027 |
| 10/26/2023 | Date of exercisable stock options with an expiration date of 10/26/2028 |
| 04/26/2024 | Date of exercisable stock options with an expiration date of 04/26/2029 |
| 05/15/2025 | Date of transaction: John Docherty acquired 150,000 stock options; Date of exercisable stock options with an expiration date of 05/15/2030 |
| 05/16/2025 | Date of signature for the Form 4 filing |
Keywords
stock options, Form 4, insider trading, beneficial ownership, Lexaria Bioscience Corp., John Docherty, LEXX, securities
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.